Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Nutex Health (NUTX) Competitors

Nutex Health logo
$118.91 +0.03 (+0.03%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$118.68 -0.22 (-0.19%)
As of 05/22/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NUTX vs. FOUR, LIF, YY, JOYY, and HAWK

Should you buy Nutex Health stock or one of its competitors? MarketBeat compares Nutex Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nutex Health include Shift4 Payments (FOUR), Life360 (LIF), JOYY (YY), JOYY (JOYY), and HawkEye 360 (HAWK). These companies are all part of the "business services" industry.

How does Nutex Health compare to Shift4 Payments?

Shift4 Payments (NYSE:FOUR) and Nutex Health (NASDAQ:NUTX) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Shift4 Payments has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Shift4 Payments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shift4 Payments$4.18B0.82$119M$0.8451.52
Nutex Health$875.26M0.93$70.79M$12.949.19

Nutex Health has a net margin of 10.95% compared to Shift4 Payments' net margin of 2.63%. Shift4 Payments' return on equity of 33.55% beat Nutex Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Shift4 Payments2.63% 33.55% 5.01%
Nutex Health 10.95%23.50%10.47%

In the previous week, Shift4 Payments had 7 more articles in the media than Nutex Health. MarketBeat recorded 7 mentions for Shift4 Payments and 0 mentions for Nutex Health. Shift4 Payments' average media sentiment score of 0.18 beat Nutex Health's score of 0.00 indicating that Shift4 Payments is being referred to more favorably in the media.

Company Overall Sentiment
Shift4 Payments Neutral
Nutex Health Neutral

Shift4 Payments has a beta of 1.44, indicating that its stock price is 44% more volatile than the broader market. Comparatively, Nutex Health has a beta of 0.25, indicating that its stock price is 75% less volatile than the broader market.

Shift4 Payments currently has a consensus target price of $71.38, suggesting a potential upside of 64.93%. Nutex Health has a consensus target price of $205.00, suggesting a potential upside of 72.40%. Given Nutex Health's stronger consensus rating and higher possible upside, analysts clearly believe Nutex Health is more favorable than Shift4 Payments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shift4 Payments
2 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.39
Nutex Health
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

98.9% of Shift4 Payments shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 25.2% of Shift4 Payments shares are owned by company insiders. Comparatively, 44.7% of Nutex Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Shift4 Payments beats Nutex Health on 9 of the 16 factors compared between the two stocks.

How does Nutex Health compare to Life360?

Nutex Health (NASDAQ:NUTX) and Life360 (NASDAQ:LIF) are both business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

Nutex Health currently has a consensus price target of $205.00, suggesting a potential upside of 72.40%. Life360 has a consensus price target of $63.94, suggesting a potential upside of 58.99%. Given Nutex Health's higher possible upside, equities analysts clearly believe Nutex Health is more favorable than Life360.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutex Health
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Life360
1 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.55

In the previous week, Life360 had 9 more articles in the media than Nutex Health. MarketBeat recorded 9 mentions for Life360 and 0 mentions for Nutex Health. Life360's average media sentiment score of 0.27 beat Nutex Health's score of 0.00 indicating that Life360 is being referred to more favorably in the news media.

Company Overall Sentiment
Nutex Health Neutral
Life360 Neutral

Life360 has a net margin of 28.21% compared to Nutex Health's net margin of 10.95%. Nutex Health's return on equity of 23.50% beat Life360's return on equity.

Company Net Margins Return on Equity Return on Assets
Nutex Health10.95% 23.50% 10.47%
Life360 28.21%6.80%3.65%

Life360 has lower revenue, but higher earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Life360, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutex Health$875.26M0.93$70.79M$12.949.19
Life360$489.48M6.66$150.83M$1.7323.25

5.3% of Nutex Health shares are held by institutional investors. Comparatively, 20.0% of Life360 shares are held by institutional investors. 44.7% of Nutex Health shares are held by insiders. Comparatively, 6.8% of Life360 shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Nutex Health has a beta of 0.25, meaning that its stock price is 75% less volatile than the broader market. Comparatively, Life360 has a beta of 2.81, meaning that its stock price is 181% more volatile than the broader market.

Summary

Life360 beats Nutex Health on 11 of the 17 factors compared between the two stocks.

How does Nutex Health compare to JOYY?

Nutex Health (NASDAQ:NUTX) and JOYY (NASDAQ:YY) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

JOYY has higher revenue and earnings than Nutex Health. JOYY is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutex Health$875.26M0.93$70.79M$12.949.19
JOYY$2.24B1.31$301.82M-$3.10N/A

Nutex Health currently has a consensus price target of $205.00, suggesting a potential upside of 72.40%. JOYY has a consensus price target of $66.00, suggesting a potential upside of 21.28%. Given Nutex Health's higher probable upside, research analysts plainly believe Nutex Health is more favorable than JOYY.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutex Health
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
JOYY
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

5.3% of Nutex Health shares are held by institutional investors. Comparatively, 36.8% of JOYY shares are held by institutional investors. 44.7% of Nutex Health shares are held by insiders. Comparatively, 43.0% of JOYY shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Nutex Health's average media sentiment score of 0.00 equaled JOYY'saverage media sentiment score.

Company Overall Sentiment
Nutex Health Neutral
JOYY Neutral

Nutex Health has a net margin of 10.95% compared to JOYY's net margin of 9.02%. Nutex Health's return on equity of 23.50% beat JOYY's return on equity.

Company Net Margins Return on Equity Return on Assets
Nutex Health10.95% 23.50% 10.47%
JOYY 9.02%4.64%2.96%

Nutex Health has a beta of 0.25, meaning that its share price is 75% less volatile than the broader market. Comparatively, JOYY has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market.

Summary

Nutex Health and JOYY tied by winning 7 of the 14 factors compared between the two stocks.

How does Nutex Health compare to JOYY?

JOYY (NASDAQ:JOYY) and Nutex Health (NASDAQ:NUTX) are both business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.

In the previous week, JOYY's average media sentiment score of 0.00 equaled Nutex Health'saverage media sentiment score.

Company Overall Sentiment
JOYY Neutral
Nutex Health Neutral

36.8% of JOYY shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 43.0% of JOYY shares are owned by insiders. Comparatively, 44.7% of Nutex Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

JOYY currently has a consensus target price of $74.67, suggesting a potential upside of 37.20%. Nutex Health has a consensus target price of $205.00, suggesting a potential upside of 72.40%. Given Nutex Health's higher possible upside, analysts plainly believe Nutex Health is more favorable than JOYY.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
JOYY
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Nutex Health
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

JOYY has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market. Comparatively, Nutex Health has a beta of 0.25, suggesting that its share price is 75% less volatile than the broader market.

JOYY has higher revenue and earnings than Nutex Health. JOYY is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JOYY$2.12B1.28$2.10B$39.031.39
Nutex Health$875.26M0.93$70.79M$12.949.19

JOYY has a net margin of 98.79% compared to Nutex Health's net margin of 10.95%. Nutex Health's return on equity of 23.50% beat JOYY's return on equity.

Company Net Margins Return on Equity Return on Assets
JOYY98.79% 3.93% 3.44%
Nutex Health 10.95%23.50%10.47%

Summary

JOYY beats Nutex Health on 8 of the 13 factors compared between the two stocks.

How does Nutex Health compare to HawkEye 360?

Nutex Health (NASDAQ:NUTX) and HawkEye 360 (NYSE:HAWK) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

In the previous week, HawkEye 360 had 3 more articles in the media than Nutex Health. MarketBeat recorded 3 mentions for HawkEye 360 and 0 mentions for Nutex Health. HawkEye 360's average media sentiment score of 0.25 beat Nutex Health's score of 0.00 indicating that HawkEye 360 is being referred to more favorably in the news media.

Company Overall Sentiment
Nutex Health Neutral
HawkEye 360 Neutral

Nutex Health has higher revenue and earnings than HawkEye 360.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutex Health$875.26M0.93$70.79M$12.949.19
HawkEye 360$177.42M15.96N/AN/AN/A

Nutex Health has a net margin of 10.95% compared to HawkEye 360's net margin of 0.00%. Nutex Health's return on equity of 23.50% beat HawkEye 360's return on equity.

Company Net Margins Return on Equity Return on Assets
Nutex Health10.95% 23.50% 10.47%
HawkEye 360 N/A N/A N/A

Nutex Health has a beta of 0.25, suggesting that its share price is 75% less volatile than the broader market. Comparatively, HawkEye 360 has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market.

5.3% of Nutex Health shares are owned by institutional investors. Comparatively, 90.7% of HawkEye 360 shares are owned by institutional investors. 44.7% of Nutex Health shares are owned by insiders. Comparatively, 3.8% of HawkEye 360 shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Nutex Health currently has a consensus price target of $205.00, suggesting a potential upside of 72.40%. Given Nutex Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Nutex Health is more favorable than HawkEye 360.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutex Health
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
HawkEye 360
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Nutex Health beats HawkEye 360 on 9 of the 14 factors compared between the two stocks.

Get Nutex Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUTX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NUTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NUTX vs. The Competition

MetricNutex HealthMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$818.05M$8.23B$6.41B$12.31B
Dividend YieldN/A2.98%2.76%5.31%
P/E Ratio9.1921.2721.0125.66
Price / Sales0.9355.78555.7183.69
Price / Cash9.2184.2044.5756.72
Price / Book1.855.9710.377.14
Net Income$70.79M$180.93M$3.56B$335.72M
7 Day Performance-5.85%59.84%5.10%3.03%
1 Month Performance8.79%48.23%3.58%2.88%
1 Year Performance-25.66%4.96%34.18%35.20%

Nutex Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NUTX
Nutex Health
2.6868 of 5 stars
$118.91
+0.0%
$205.00
+72.4%
-26.5%$818.05M$875.26M9.191,150
FOUR
Shift4 Payments
4.5497 of 5 stars
$41.98
-1.2%
$71.38
+70.0%
-50.5%$3.34B$4.18B50.176,300
LIF
Life360
4.1294 of 5 stars
$38.95
-1.3%
$63.94
+64.2%
-33.7%$3.16B$528.98M22.53600
YY
JOYY
2.9094 of 5 stars
$57.22
+1.6%
$66.00
+15.3%
+29.8%$3.08B$2.24B17.297,450
JOYY
JOYY
4.5498 of 5 stars
$57.08
-0.3%
$74.67
+30.8%
N/A$2.85B$2.12B1.465,421

Related Companies and Tools


This page (NASDAQ:NUTX) was last updated on 5/23/2026 by MarketBeat.com Staff.
From Our Partners